These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3312728)

  • 1. Highly sensitive analysis of gangliosides in human cerebrospinal fluid with neurological diseases.
    Yamanaka T; Hirabayashi Y; Koketsu K; Higashi H; Matsumoto M
    Jpn J Exp Med; 1987 Apr; 57(2):131-5. PubMed ID: 3312728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive enzyme-immunostaining and densitometric determination of ganglio-series gangliosides on thin-layer plate: pmol detection of gangliosides in cerebrospinal fluid.
    Hirabayashi Y; Koketsu K; Higashi H; Suzuki Y; Matsumoto M; Sugimoto M; Ogawa T
    Biochim Biophys Acta; 1986 Mar; 876(1):178-82. PubMed ID: 3511969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gangliosides in human cerebrospinal fluid].
    Bernheimer H
    Klin Wochenschr; 1969 Feb; 47(4):227-8. PubMed ID: 5369575
    [No Abstract]   [Full Text] [Related]  

  • 4. Gangliosides of human cerebrospinal fluid in various neurologic diseases.
    Trbojevic-Cepe M; Kracun I; Jusic A; Pavlicek I
    J Neurol Sci; 1991 Oct; 105(2):192-9. PubMed ID: 1661775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gangliosides and sulphatide in human cerebrospinal fluid: quantitation with immunoaffinity techniques.
    Davidsson P; Fredman P; Svennerholm L
    J Chromatogr; 1989 Nov; 496(2):279-89. PubMed ID: 2613833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gangliosides in children with autism.
    Lekman A; Skjeldal O; Sponheim E; Svennerholm L
    Acta Paediatr; 1995 Jul; 84(7):787-90. PubMed ID: 7549298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of ganglioside Gm2 in cerebrospinal fluid of a patient with the variant AB of infantile Gm2 gangliosidosis.
    Pullarkat RK; Reha H; Beratis NG
    Pediatrics; 1981 Jul; 68(1):106-8. PubMed ID: 7243492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of gangliosides and sulfatide in human cerebrospinal fluid with a microimmunoaffinity technique.
    Davidsson P; Fredman P; Månsson JE; Svennerholm L
    Clin Chim Acta; 1991 Mar; 197(2):105-15. PubMed ID: 2049855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoelectric focusing and immunofixation of cerebrospinal fluid oligoclonal IgG in neurological disorders.
    Rubin DB; Mehta PD; Nathanson M
    Diagn Immunol; 1985; 3(3):160-2. PubMed ID: 4053495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal developmental profiles of CSF gangliotetraose-series gangliosides from neonatal period to adolescence.
    Izumi T; Ogawa T; Koizumi H; Fukuyama Y
    Pediatr Neurol; 1993; 9(4):297-300. PubMed ID: 8216543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic recurrent polyneuropathy in a patient with autoimmune hemolytic anemia associated with antibodies to gangliosides GM1, GA1, and GD1b].
    Nomura K; Kaneko A; Iwasaki A; Ino H; Hirashima K; Hamaguchi K
    Rinsho Shinkeigaku; 1995 Oct; 35(10):1131-6. PubMed ID: 8821498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective detection of terminally alpha 2-3 and alpha 2-6 sialylated neolacto-series gangliosides by immunostaining on thin layer chromatograms.
    Müthing J; Neumann U
    Biomed Chromatogr; 1993; 7(3):158-61. PubMed ID: 8318834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiotensin I-converting enzyme in cerebrospinal fluid and neurosarcoidosis].
    Baudin B; Bénéteau-Burnat B; Vaubourdolle M
    Ann Biol Clin (Paris); 2005; 63(5):475-80. PubMed ID: 16230281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A radioassay for GM1 ganglioside concentration in cerebrospinal fluid.
    Ginns E; French J
    J Neurochem; 1980 Oct; 35(4):977-82. PubMed ID: 7005403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplified ELISA to detect autoantibodies to N-glycolyl-GM3 ganglioside.
    Iznaga N; Carr A; Fernández LE; Solozabal J; Núñez G; Perdomo Y; Morales A
    J Clin Lab Immunol; 1996; 48(2):75-85. PubMed ID: 16296265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of dopamine-releasing protein (DARP) in cerebrospinal fluid of patients with neurological disorders.
    Verdugo-Diaz L; Morgado-Valle C; Solis-Maldonado G; Drucker-Colin R
    Arch Med Res; 1997; 28(4):577-81. PubMed ID: 9428587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of cerebrospinal fluid immunoglobulins in various neurological diseases.
    Hirohata S; Inoue T; Iwamoto S; Hirose S; Miyamoto T
    Arerugi; 1984 Apr; 33(4):242-6. PubMed ID: 6383275
    [No Abstract]   [Full Text] [Related]  

  • 18. [Superoxide dismutase in cerebrospinal fluid in patients with neurological diseases].
    Yoshida E; Mokuno K; Aoki S; Takahashi A; Kato K
    Rinsho Shinkeigaku; 1993 Jan; 33(1):21-6. PubMed ID: 8334770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low levels of CSF gangliotetraose-series gangliosides in West syndrome: implication of brain maturation disturbance.
    Izumi T; Ogawa T; Koizumi H; Fukuyama Y
    Pediatr Neurol; 1993; 9(4):293-6. PubMed ID: 8216542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganglioside complexes as new target antigens in Guillain-Barré syndrome.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    Ann Neurol; 2004 Oct; 56(4):567-71. PubMed ID: 15389898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.